Preventive efforts may reduce neonatal group B streptococcus.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use; D013290:Streptococcal Infections / Q000517:prevention & control*; D013292:Streptococcus agalactiae; D013745:Tetanus Toxoid / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D011135:Polysaccharides, Bacterial; D013745:Tetanus Toxoid